ZA941209B - Optical isomerization inhibitor - Google Patents

Optical isomerization inhibitor

Info

Publication number
ZA941209B
ZA941209B ZA941209A ZA941209A ZA941209B ZA 941209 B ZA941209 B ZA 941209B ZA 941209 A ZA941209 A ZA 941209A ZA 941209 A ZA941209 A ZA 941209A ZA 941209 B ZA941209 B ZA 941209B
Authority
ZA
South Africa
Prior art keywords
optical isomerization
isomerization inhibitor
inhibitor
optical
isomerization
Prior art date
Application number
ZA941209A
Other languages
English (en)
Inventor
Shinichi Fukuyama
Keiichi Nakashima
Noritsugu Morokoshi
Shigetaka Koda
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ZA941209B publication Critical patent/ZA941209B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/04—Use of additives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA941209A 1993-03-03 1994-02-22 Optical isomerization inhibitor ZA941209B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4243093 1993-03-03

Publications (1)

Publication Number Publication Date
ZA941209B true ZA941209B (en) 1994-09-19

Family

ID=12635853

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941209A ZA941209B (en) 1993-03-03 1994-02-22 Optical isomerization inhibitor

Country Status (10)

Country Link
EP (1) EP0687473A1 (zh)
KR (1) KR960700753A (zh)
CN (1) CN1118575A (zh)
AU (1) AU6045994A (zh)
CA (1) CA2157383A1 (zh)
HU (1) HUT70950A (zh)
IL (1) IL108810A0 (zh)
TW (1) TW264390B (zh)
WO (1) WO1994020143A1 (zh)
ZA (1) ZA941209B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
AUPQ899400A0 (en) * 2000-07-26 2000-08-17 Csl Limited A method of stabilisation and compositions for use therein
US20070129340A1 (en) * 2004-02-06 2007-06-07 Chugai Seiyaku Kabushiki Kaisha Ed-71 preparation
US20070292501A1 (en) * 2006-06-05 2007-12-20 Udell Ronald G Chewable soft gelatin capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56127309A (en) * 1980-03-11 1981-10-06 Dai Ichi Seiyaku Co Ltd Zeolite support for ascorbic acid
JPS5780328A (en) * 1980-11-06 1982-05-19 Sumitomo Chem Co Ltd Preparation of stable pharmaceutical preparation
JPS649285A (en) * 1987-06-30 1989-01-12 Shiseido Co Ltd Antioxidant
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Benzodiazepinone compounds [4,1] connected via positions 1 and 9 and carrying two transducers, processes for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
EP0687473A4 (zh) 1996-01-24
KR960700753A (ko) 1996-02-24
HU9402538D0 (en) 1994-11-28
CA2157383A1 (en) 1994-09-15
AU6045994A (en) 1994-09-26
CN1118575A (zh) 1996-03-13
EP0687473A1 (en) 1995-12-20
WO1994020143A1 (en) 1994-09-15
HUT70950A (en) 1995-11-28
IL108810A0 (en) 1994-06-24
TW264390B (zh) 1995-12-01

Similar Documents

Publication Publication Date Title
SG50569A1 (en) Optical component
SG94794A1 (en) Optical component
GB9315231D0 (en) Optical time domain reflextometry
IL111218A0 (en) Optical systems
CA75393S (en) Light
GB2277721B (en) Optical ranging
GB2274520B (en) Optical devices
GB2274727B (en) Optical system
GB2277808B (en) Optical devices
ZA941209B (en) Optical isomerization inhibitor
GB2284903B (en) Optical system
ZA944346B (en) New optical isomers
ZA939480B (en) Enzyme inhibitor
GB2282235B (en) Optical star-coupler
GB2279681B (en) Reflective studs
AU3967293A (en) Light plus
GB2276465B (en) Optical devices
GB2274658B (en) Optical store
GB9323583D0 (en) Light genertaator
GB2444544B (en) Optical Delay Line Arrangement
GB9306792D0 (en) Optic guidway
GB9304910D0 (en) Optical systems
GB9312169D0 (en) Optical devices
GB9201664D0 (en) Geolographic stress inhibitor
GB9222948D0 (en) Geolographic stress inhibitor